EyeGene Inc
KOSDAQ:185490
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
EyeGene Inc
KOSDAQ:185490
|
KR |
|
S
|
S A F Special Steel PCL
SET:SAF
|
TH |
|
Patagonia Gold Corp
XTSX:PGDC
|
AR |
|
S
|
Standard Energy Corp
OTC:STDE
|
US |
|
D
|
DOD Biotech PCL
SET:DOD
|
TH |
|
Microprogram Information Co Ltd
TWSE:7721
|
TW |
|
D
|
Devmar Equities Inc
OTC:DEVM
|
US |
|
A
|
Asarina Pharma AB (publ)
XBER:APS
|
SE |
|
Moliera2 SA
F:8F4
|
PL |
|
Fansfrenzy Corp
OTC:FFZY
|
CA |
|
E
|
E Pairis SA
ATHEX:PAIR
|
GR |
|
Dottikon Es Holding AG
SIX:DESN
|
CH |
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
KR |
|
Partners Group Holding AG
OTC:PGPHF
|
CH |
|
Lawfinance Ltd
ASX:LAW
|
AU |
|
E
|
Ecoloclean Industries Inc
OTC:ECCI
|
US |
|
GPI SpA
F:Z44
|
IT |
|
E
|
EUROKAI GmbH & Co KgaA
F:EUK3
|
DE |
|
Medincell SA
F:MEB
|
FR |
|
S
|
Shin Yang Shipping Corporation Bhd
KLSE:SYSCORP
|
MY |
Shareholder Yield
Current shareholder yield for EyeGene Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
EyeGene Inc
| Average Annual Return | -44.48% |
| Standard Deviation of Annual Returns | 24.88% |
| Max Drawdown | -97% |
| Market Capitalization | 87.1B KRW |
| Shares Outstanding | 43 230 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
EyeGene Inc's latest stock split occurred on Oct 24, 2025
The company executed a 4114-for-3521 stock split, meaning that for every 3521 shares held, investors received 4114 new shares.
Before the split, EyeGene Inc traded at 2270.002 per share. Afterward, the share price was about 2045.
The adjusted shares began trading on Oct 24, 2025. This was stock split number 3 in EyeGene Inc's history, following the previous one in Jun 28, 2021.
